Correlation Between Oncolytics Biotech and Quebecor

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Quebecor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Quebecor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Quebecor, you can compare the effects of market volatilities on Oncolytics Biotech and Quebecor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Quebecor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Quebecor.

Diversification Opportunities for Oncolytics Biotech and Quebecor

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Oncolytics and Quebecor is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Quebecor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quebecor and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Quebecor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quebecor has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Quebecor go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and Quebecor

Assuming the 90 days trading horizon Oncolytics Biotech is expected to under-perform the Quebecor. In addition to that, Oncolytics Biotech is 1.58 times more volatile than Quebecor. It trades about -0.04 of its total potential returns per unit of risk. Quebecor is currently generating about 0.0 per unit of volatility. If you would invest  3,199  in Quebecor on October 28, 2024 and sell it today you would lose (61.00) from holding Quebecor or give up 1.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Oncolytics Biotech  vs.  Quebecor

 Performance 
       Timeline  
Oncolytics Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Quebecor 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Quebecor has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Oncolytics Biotech and Quebecor Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncolytics Biotech and Quebecor

The main advantage of trading using opposite Oncolytics Biotech and Quebecor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Quebecor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quebecor will offset losses from the drop in Quebecor's long position.
The idea behind Oncolytics Biotech and Quebecor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Directory
Find actively traded commodities issued by global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume